Summary
The inactivation of several types of African horse sickness virus (AHSV) by pH and by betapropiolactone (BPL) was studied. At 19°–22° C the virus was stable between pH 6.0 and 10.4, whether suspended in mouse brain or in serum-free buffer. Below pH 5.6 and above pH 10.9, more than 99 per cent of infectivity was inactivated within 15 minutes. The addition of 50 per cent serum did not influence pH stability. Disinfection in the presence of citric acid and caustic soda is briefly discussed.
Inactivation by BPL was complete within 30 minutes at 37° C, yet incomplete after 15 hours at 4° C. Types 3 and 9 virus grown in suckling mouse brain and types 1, 3 and 9 produced in pig kidney cells were equally susceptible to 0.1 per cent BPL, more than 99.9 per cent being inactivated. The effectiveness of BPL was reduced at least 10-fold by the addition of 50 per cent serum.
No infective virus was detected following incubation of either tissue culture virus with 0.2 per cent BPL or of mouse brain virus with 0.3 per cent BPL. Virus suspensions exposed to 0.3 per cent BPL required buffering with Tris of at least 0.05 molar strength in order to maintain the pH within an acceptable range. Inactivated antigens prepared with 0.4 per cent or lower concentrations of BPL were immunogenic in guinea pigs.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Alexander, R. A.: Studies on the neutropic virus of horse sickness. II. Some physical and chemical properties. Onderstepoort J. vet. Sci. Anim. Ind.4, 323–348 (1935).
Brand, O. M., Allen, W. P.: Preparation of non-infectious arbovirus antigens. Appl. Microbiol.20, 298–302 (1970).
De Castro, M. P.: Behaviour of the foot-and-mouth disease virus in cell cultures: susceptibility of the IB-RS-2 cell line. Arch. Inst. biol. (S. Paulo)31, 63–78 (1964).
Dulbecco, R., Vogt, M.: Plaque formation and isolation of pure line with poliomyelitis viruses. J. exp. Med.99, 167–182 (1954).
Erasmus, B. J.: Preliminary observations on the value of the guinea pig in determining the innocuity and antigenicity of neurotropic attenuated horse sickness strains. Onderstepoort J. vet. Res.30, 11–21 (1963).
French, G. R., McKinney, R. W.: Use of β-propiolactone in preparation of inactivated arbovirus serologic test antigens. J. Immunol.92, 772–778 (1964).
Good, N. E., Winget, G. D., Winter, W., Connolly, T. N., Izawa, S., Singh, R. M. M.: Hydrogen ion buffers for biological research. Biochemistry5, 467–477 (1966).
Herniman, K. A. J., Medhurst, P. M., Wilson, J. N., Sellers, R. F.: The action of heat, chemicals and disinfectants on swine vesicular disease virus. Vet. Rec.93, 620–624 (1973).
Howell, P. G.: The isolation and identification of further antigenic types of African horse sickness virus. Onderstepoort J. vet. Res.29, 139–149 (1962).
Howell, P. G.: African horse sickness. In: Emerging Diseases of Animals. F.A.O. Agricultural Studies No.61, 71–108. Rome (1963).
Kärber, G.: Beitrag zur kollectiven Behandlung pharmakologischer Reihenversuche Nauryn-Schmiedeberg's. Arch. exp. Path. Pharmak.162, 480–483 (1931).
LoGrippo, G. A.: Antigenicity of combined β-propiolactone and ultra-violet inactivated virus vaccines. J. Immunol.80, 198–203 (1958).
LoGrippo, G. A.: Investigations of the use of beta-propiolactone in virus inactivation. Ann. N.Y. Acad. Sci.83, 578–594 (1959).
LoGrippo, G. A., Hartman, F. W.: Antigenicity of β-propiolactone-inactivated virus vaccines. J. Immunol.75, 123–128 (1955).
Mack, W. N., Chotisen, A.: Serological response in chickens to beta-propiolactone-treated Newcastle disease virus. Proc. Soc. exp. Biol. (N.Y.)91, 288–290 (1956).
Macpherson, I. A., Stoker, M. G. P.: Polyoma transformation of hamster cell clones—an investigation of genetic factors affecting cell competence. Virology16, 147–151 (1962).
Mirchamsy, H., Taslimi, H.: Inactivated African horse sickness virus cell culture vaccine. Immunology14, 81–88 (1968).
Oellermann, R. A., Els, H. J., Erasmus, B. J.: Characterization of African horse sickness virus. Arch. ges. Virusforsch.29, 163–174 (1970).
Parker, J.: African horse sickness virus antibodies in Cyprus—1971–72. Vet. Rec.94, 370–373 (1974).
Parker, J., Herniman, K. A. J., Gibbs, E. P. J., Sellers, R. F.: An experimental inactivated vaccine against bluetongue. Vet. Rec. (in press.)
Schmitz-Masse, M. O.: Analyse de la β-propiolactone par chromatographie gazliquide. J. Chromatogr.70, 128–134 (1972).
Sellers, R. F.: The inactivation of foot-and-mouth disease virus by chemicals and disinfectants. Vet. Rec.83, 504–506 (1968).
Ubertini, B., Nardelli, L., Santero, G., Cessi, D.: Recherches sur l'inactivation du virus aphteux et du virus de Newcastle par la beta-propiolactone (BPL) et le formol. Schweiz. Arch. Tierheilk.99, 309–328 (1957).
Wiktor, T. J., Sokol, F., Kuwert, E., Koprowski, H.: Immunogenicity of concentrated and purified rabies vaccine of tissue culture origin. Proc. Soc. exp. Biol. (N.Y.)131, 799–805 (1969).
Williamson, J. D., Cox, P.: Use of a new buffer in the culture of animal cells. J. gen. Virol.2, 309–312 (1968).
Author information
Authors and Affiliations
Additional information
With 2 Figures
Rights and permissions
About this article
Cite this article
Parker, J. Inactivation of African horse-sickness virus by betapropiolactone and by pH. Archives of Virology 47, 357–365 (1975). https://doi.org/10.1007/BF01347977
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF01347977